Skip to main content
      Dr. @karen_kc123 discusses the results of the VITAL study.
      - Long term use of Vit D3 2000IU was safe and decreased the i

      sheila RHEUMarampa

      9 months 3 weeks ago
      Dr. @karen_kc123 discusses the results of the VITAL study. - Long term use of Vit D3 2000IU was safe and decreased the incidence of all autoimmune dses by 22%. - It took a while to work but the effect dissipates once discontinued. @RheumNow #ACR24 @rheumarhyme https://t.co/mnwRsdZ06N
      Will be covering some TAK pearls and pitfalls from today’s session!

      Renal dz stratified by location of vessel inflamm

      Brian Jaros, MD Dr_Brian_MD

      9 months 3 weeks ago
      Will be covering some TAK pearls and pitfalls from today’s session! Renal dz stratified by location of vessel inflammation: - TAK = proximal (off aorta) - FMD = mid-section, beading - PAN = distal arterial branches @RheumNow #ACR24 https://t.co/zu6qJ6DXcF
      A call for ANA stewardship?

      Abstract 1931: Educating clinicians on wise ANA ordering via EMR Alert plus removing the co

      Akhil Sood MD AkhilSoodMD

      9 months 3 weeks ago
      A call for ANA stewardship? Abstract 1931: Educating clinicians on wise ANA ordering via EMR Alert plus removing the comprehensive ANA panel --> - ↓ ANA testing (outpatient 15.9%→7.4%, inpatient 25.5%→6.4%) ↓ costs ($440k→$130k) #ACR24 @RheumNow
      Study of 25K+ patients using TrinetX on immune checkpoint inhibitors shows no significant mortality difference between t

      Antoni Chan MD (Prof) synovialjoints

      9 months 3 weeks ago
      Study of 25K+ patients using TrinetX on immune checkpoint inhibitors shows no significant mortality difference between those with pre-existing autoimmune disease (AID) and those without. Mortality rates: AID: 39.8% Non-AID: 40.2% Large-scale evidence supports ICIs in AID… https://t.co/BI5jK9jsoM
      A#2531 @AlisaMueller
      CRISPR deletion of fibroblasts, gave cytokine activation to mimic inflamm
      Are there gene depletion

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      A#2531 @AlisaMueller CRISPR deletion of fibroblasts, gave cytokine activation to mimic inflamm Are there gene depletions that affect inflamm pathways? 👉SIX1 reduces inflamm potentiation 👉NFIL3 deletion promotes inflamm, degradation @RheumNow #ACR24 https://t.co/Nqghb5UaBR
      A#2532
      Pre-existing AID for immunoRx?
      Excluded from trials
      4 prior studies showed no diff in mortality w AID
      Propensity-

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      A#2532 Pre-existing AID for immunoRx? Excluded from trials 4 prior studies showed no diff in mortality w AID Propensity-matched cohort study Followed median 250 days Hazard ratio: 1.07 (unmatched), 0.97 (matched) - no diff. Mortality about 40% in grps @RheumNow #ACR24 https://t.co/zyVCPts6s6
      Imaging in TAK Diagnosis
      @KQuinnRheum @RheumNow

      ⭐ Take homes ⭐

      👉location of renal artery stenosis (RAS) key t

      Patricia Harkins DrTrishHarkins

      9 months 3 weeks ago
      Imaging in TAK Diagnosis @KQuinnRheum @RheumNow ⭐ Take homes ⭐ 👉location of renal artery stenosis (RAS) key to making Dx with proximal RAS in TAK 👉FDG PET -focal uptake in TAK vs diffuse in GCA 👉MRI good surrogate for disease activity where PET unavailable #ACR24 https://t.co/UWxTAZScIt
      Mental health, sex, and comorbidities are key factors in determining recalcitrant psoriatic arthritis (PsA).
      Key finding

      Antoni Chan MD (Prof) synovialjoints

      9 months 3 weeks ago
      Mental health, sex, and comorbidities are key factors in determining recalcitrant psoriatic arthritis (PsA). Key findings: - 21.7% of patients required ≥4 biologic/targeted synthetic DMARDs. - Female patients and those with depression were more likely to be recalcitrant. - No… https://t.co/I9YYoRnLwh https://t.co/VtnPceVLOZ
      the predictive value of a positive ANA test—especially in the absence of other clinical symptoms—remains a challenge. A positive test often leads to further testing, yet it does not necessarily indicate whether a patient truly has an underlying autoimmune disease. The development of AI and machine learning algorithms presents an opportunity to interpret autoantibody tests and predict autoimmune diseases. Here are three studies looking at this
      Treating SpA
      #ACR24 - Featured Industry Presentations

      Many of the great presentations for this meeting come from industry sponsored

      Dr. John Cush RheumNow

      9 months 3 weeks ago
      #ACR24 - Featured Industry Presentations Many of the great presentations for this meeting come from industry sponsored clinical trials and reports. Often these become the pivotal studies for regulatory approval and the annual congresses are their first look.… https://t.co/I6LMQ5xMUx https://t.co/UzTeqWUSdo
      The precise mechanism of action of GIOP is not known. Decrease in osteocyte LCN is observed. Abstr#2528 @RheumNow #ACR24

      Antoni Chan MD (Prof) synovialjoints

      9 months 3 weeks ago
      The precise mechanism of action of GIOP is not known. Decrease in osteocyte LCN is observed. Abstr#2528 @RheumNow #ACR24 https://t.co/fazUUy03fQ
      In earlier studies of Vit D, there were conflicting evidence as to whether it reduced or increased the risk of RA and #S

      sheila RHEUMarampa

      9 months 3 weeks ago
      In earlier studies of Vit D, there were conflicting evidence as to whether it reduced or increased the risk of RA and #SLE @RheumNow #ACR24 @rheumarhyme https://t.co/PvjjmhHaOd
      ×